- Admin
- #1
Given their recent performance, it's safe to say that both are monster growth stocks -- and if you're willing to buy them hand over fist, you'll be doing your portfolio a favor. With its shares burgeoning by more than 959% over the last 10 years, obliterating the market's return of around 260%, Thermo Fisher Scientific (NYSE: TMO) might seem like an improbable contender for being an ultra-growth stock at first glance. Its primary line of business is selling instruments, supplies, and other laboratory hardware to life sciences companies, and it also sells diagnostic tests to hospitals and clinics.